Initiation of GLP-1RA was defined as a new prescription of any GLP-1RA available in Italy (exenatide BID, exenatide OW, lixisenatide, liraglutide, dulaglutide, semaglutide OW, oral semaglutide) for patients who had never been treated with the same compound before, as evident from the diabetes treatment history recorded in the electronic chart
This tag-team approach also means patients may experience more substantial weight loss results compared to medications that only target GLP-1 receptors
B12 deficiency causes fatigue, poor exercise tolerance, impaired cognition, and in severe cases peripheral neuropathy
Specifically, NRF2 is a transcription factor that governs the antioxidant pathway by targeting GSH metabolism-related genes
Abnormalities in membrane phospholipid organization in sickled erythrocytes